. Author manuscript; available in PMC: 2023 Jan 1.

Published in final edited form as: J Clin Gastroenterol. 2021 Oct 4;56(10):853–862. doi: 10.1097/MCG.0000000000001622

Table 3.

Other outcomes reported stratified according to diverticulum location (Zenker’s versus epiphrenic)

Outcome	Subgroup	No. of Cohorts	No. of patients	Summary Estimate (95% CI)	Within-group heterogeneity (I²)
Technical success	Zenker’s	8	260	95.9% (93.4%–98.3%)	0%
Technical success	Epiphrenic	5	40	95.1% (88.8%–100%)	0%
Symptoms recurrence	Zenker’s	8	260	2.6% (0.9%–4.4%)	0%
Symptoms recurrence	Epiphrenic	5	40	0%	0%
Adverse events	Zenker’s	8	260	10.6% (4.6%–16.6%)	47.2%
Adverse events	Epiphrenic	5	40	8.4% (0%–16.8%)	0%
Severe adverse events	Zenker’s	8	260	3.5% (0%–7.4%)	62.3%
Severe adverse events	Epiphrenic	5	40	8.4% (0.1%–16.8%)	0%
Procedure time	Zenker’s	7	233	44.7 min (30.03–59.4)	45%
Procedure time	Epiphrenic	2	33	61.7 min (38.4–84.9)	41%
Length of hospital stay	Zenker’s	7	233	1.23 days (1–1.4)	48%
Length of hospital stay	Epiphrenic	2	33	5.6 days (4.8–6.4)	44.3%

Abbreviation: CI, Confidence Interval.